Found 320 articles for: "alopecia"
An Update on the Off-Label Uses of Low-Dose Naltrexone in Dermatology
December 2024 | Volume 23 | Issue 12 | Features | 1127 | Copyright © December 2024
Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1076 | Copyright © December 2024
Scarring alopecia, also known as cicatricial alopecia, is a group of hair loss disorders characterized by inflammatory destruction of hair follicles, leading to hair loss and scar tissue formatio...
Read MoreGLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations
November 2024 | Volume 23 | Issue 11 | Features | 1026 | Copyright © November 2024
Critical Insights on Preparation of Platelet-Rich Plasma in Tubes With a Thixotropic Gel Separator
November 2024 | Volume 23 | Issue 11 | Original Article | 979 | Copyright © November 2024
Thixotropic gels are the preferred choice in the collection of platelet-rich plasma as an easy solution to operator variability. One often unnoticed shortcoming is the entrapment of platelets in ...
Read MoreEfficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia
November 2024 | Volume 23 | Issue 11 | Original Article | 1003 | Copyright © November 2024
Background: Androgenetic Alopecia (AGA) (male pattern hair loss) is the most common form of alopecia in men, affecting 30% of men by the age of 30 years and 50% by the age of 50 ...
Read MoreReply to "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers"
October 2024 | Volume 23 | Issue 10 | Editorials | 905 | Copyright © October 2024
The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors
October 2024 | Volume 23 | Issue 10 | Original Article | 852 | Copyright © October 2024
Janus kinase inhibitors (JAKis) have recently emerged in the arsenal of tools to treat dermatological conditions. However, there are some concerns regarding these treatments due to their boxed wa...
Read MoreEvaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy
September 2024 | Volume 23 | Issue 9 | Original Article | 725 | Copyright © September 2024
Background: Minoxidil is an anti-hypertensive vasodilator increasingly used off-label for the treatment of alopecia. It is associated with an increased risk of pericardial effusi...
Read MoreResponse to "The Potential Impact of Off-Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability"
September 2024 | Volume 23 | Issue 9 | Editorials | e175 | Copyright © September 2024
Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety
September 2024 | Volume 23 | Issue 9 | Features | 790 | Copyright © September 2024
Platelet-rich concentrates (PRCs), derived from a patient's blood, are being used in various fields of medicine, including dermatology, for an increasing number of indications. Although considere...
Read MoreCross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists
September 2024 | Volume 23 | Issue 9 | Editorials | e181 | Copyright © September 2024
Dermatologic Procedures for the Treatment of Seborrheic Dermatitis
October 2024 | Volume 23 | Issue 10 | Original Article | 819 | Copyright © October 2024
Background: This paper examines alternative procedural interventions for Seborrheic Dermatitis (SD), aiming to offer clinicians more treatment options and encourage further resea...
Read MoreINDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors
August 2024 | Volume 23 | Issue 8 | Supplement Individual Articles | 85411s3 | Copyright © August 2024
Background: In the Nordic European Countries, cancer is the leading cause of death. The last decade has brought revolutionizing cancer treatments including immune checkpoint inhi...
Read MoreSelective Tyrosine Kinase 2 (TYK2) Inhibition in Plaque Psoriasis
August 2024 | Volume 23 | Issue 8 | Original Article | 645 | Copyright © August 2024
Members of the Janus kinase (JAK) superfamily, comprising tyrosine kinase 2 (TYK2) and JAK1, JAK2, and JAK3, mediate signaling by cytokines (eg, interleukin [IL]-23) involved in psoriasis pathoge...
Read MoreA Prospective, Multi-Center Study to Evaluate the Safety and Efficacy of a Vegan Nutraceutical to Improve Hair Growth and Quality in Females Following a Plant-Based Diet
August 2024 | Volume 23 | Issue 8 | Original Article | 661 | Copyright © August 2024
Hair thinning affects upwards of 50% of women by age 50, impacting their social-emotional wellbeing. It is a condition now thought to be driven by a multi-factorial etiology, including diet and n...
Read MoreTikTok and Dermatology: Questioning the Data
August 2024 | Volume 23 | Issue 8 | Features | e167 | Copyright © August 2024
The Treatment of Psoriasis With Intramuscular Triamcinolone
August 2024 | Volume 23 | Issue 8 | Features | 688 | Copyright © August 2024
Challenges in Adult Acne and the Role of Skin Care in Managing the Condition
August 2024 | Volume 23 | Issue 8 | Original Article | 674 | Copyright © August 2024
Background: Acne vulgaris is a complex, multifactorial, inflammatory skin condition. Although frequently presented at dermatology clinics, the literature on adult acne is scarce,...
Read MoreUnderrepresentation of Skin of Color in Google Images Search of Common Skin, Hair, and Nail Conditions
July 2024 | Volume 23 | Issue 7 | Editorials | e161 | Copyright © July 2024
An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color
June 2024 | Volume 23 | Issue 6 | Original Article | 410 | Copyright © June 2024
Media and other results for: "alopecia"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
